Please login to the form below

Not currently logged in
Email:
Password:

Intellectual property

This page shows the latest Intellectual property news and features for those working in and with pharma, biotech and healthcare.

Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’

Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’

Pfizer has cautioned against removing intellectual property (IP) protections in a submission to an Australian parliamentary inquiry into vaccine fraud. ... premise that their intellectual property will be protected,” he added.

Latest news

More from news
Approximately 4 fully matching, plus 291 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 42 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...